AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin

Bibliographic Details
Title: AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin
Authors: Cai, Junting, Wei, Jianxin, Li, Shuang, Suber, Tomeka, Zhao, Jing
Source: Mediators of inflammation. 2017(2):6893560-6893560
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN611525587&indx=1&recIds=ETOCRN611525587
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:09629351
Published in:Mediators of inflammation
Language:English